Jan 03, 2017 13:01 pm UTC| Business
SAN DIEGO, Jan. 03, 2017 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related...
Qorvo® Introduces Multi-protocol System on Chip for Smarter, More Secure Homes
Jan 03, 2017 13:01 pm UTC| Business
GREENSBORO, N.C., Jan. 03, 2017 -- Qorvo® (Nasdaq:QRVO), a leading provider of innovative RF solutions that connect the world, today introduced a complete system on chip (SoC) for smart home devices that delivers...
Qorvo® Introduces Multi-protocol System on Chip for Smarter, More Secure Homes
Jan 03, 2017 13:01 pm UTC| Business
GREENSBORO, N.C., Jan. 03, 2017 -- Qorvo® (Nasdaq:QRVO), a leading provider of innovative RF solutions that connect the world, today introduced a complete system on chip (SoC) for smart home devices that delivers...
Jan 03, 2017 13:01 pm UTC| Business
New Product Debuts: Gentexs biometric mirror authenticates the driver and...
Jan 03, 2017 13:01 pm UTC| Business
New Product Debuts: Gentexs biometric mirror authenticates the driver and...
Jan 03, 2017 13:01 pm UTC| Business
Therapeutic candidate IVA337 is a next generation PanPPAR agonist addressing all the relevant clinical and regulatory features of NASHNATIVE clinical study plans to enroll 225 patients in 12 European countriesHeadline...
Jan 03, 2017 13:01 pm UTC| Business
Therapeutic candidate IVA337 is a next generation PanPPAR agonist addressing all the relevant clinical and regulatory features of NASHNATIVE clinical study plans to enroll 225 patients in 12 European countriesHeadline...